183 related articles for article (PubMed ID: 33342421)
21. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the Severe Acute Respiratory Syndrome Coronavirus-2 Receptor, Angiotensin-Converting Enzyme 2, in Diabetic Kidney Disease: Implications for Kidney Injury in Novel Coronavirus Disease 2019.
Gilbert RE; Caldwell L; Misra PS; Chan K; Burns KD; Wrana JL; Yuen DA
Can J Diabetes; 2021 Mar; 45(2):162-166.e1. PubMed ID: 32917504
[TBL] [Abstract][Full Text] [Related]
23. The Angiotensin Converting Enzyme Deletion/Deletion Genotype Is a Risk Factor for Severe COVID-19: Implication and Utility for Patients Admitted to Emergency Department.
Annunziata A; Coppola A; Di Spirito V; Cauteruccio R; Marotta A; Micco PD; Fiorentino G
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441050
[No Abstract] [Full Text] [Related]
24. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
Brojakowska A; Narula J; Shimony R; Bander J
J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401
[TBL] [Abstract][Full Text] [Related]
25. Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome.
Kaparianos A; Argyropoulou E
Curr Med Chem; 2011; 18(23):3506-15. PubMed ID: 21756232
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-converting enzyme 2 in lung diseases.
Kuba K; Imai Y; Penninger JM
Curr Opin Pharmacol; 2006 Jun; 6(3):271-6. PubMed ID: 16581295
[TBL] [Abstract][Full Text] [Related]
27. [ACE2 and coronavirus - a question of balance and dynamics?].
Lundström A; Sandén P
Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
[TBL] [Abstract][Full Text] [Related]
28. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
Steckelings UM; Sumners C
Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
[TBL] [Abstract][Full Text] [Related]
29. Role of Renin-Angiotensin System in Acute Lung Injury Caused by Viral Infection.
Gao YL; Du Y; Zhang C; Cheng C; Yang HY; Jin YF; Duan GC; Chen SY
Infect Drug Resist; 2020; 13():3715-3725. PubMed ID: 33116692
[TBL] [Abstract][Full Text] [Related]
30. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
[TBL] [Abstract][Full Text] [Related]
31. The role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19: the villain or the hero?
Klhůfek J
Acta Clin Belg; 2022 Feb; 77(1):211-218. PubMed ID: 32597377
[TBL] [Abstract][Full Text] [Related]
32. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?
Vitiello A; Ferrara F
Eur J Pharmacol; 2020 Sep; 883():173373. PubMed ID: 32679185
[TBL] [Abstract][Full Text] [Related]
33. RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance.
Melissa Hallow K; Dave I
Clin Pharmacol Ther; 2021 Apr; 109(4):1092-1103. PubMed ID: 33506503
[TBL] [Abstract][Full Text] [Related]
34. Serum ACE activity and plasma ACE concentration in patients with SARS-CoV-2 infection.
Henry BM; Benoit JL; Rose J; de Oliveira MHS; Lippi G; Benoit SW
Scand J Clin Lab Invest; 2021 Jul; 81(4):272-275. PubMed ID: 34003706
[TBL] [Abstract][Full Text] [Related]
35. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
[TBL] [Abstract][Full Text] [Related]
36. The Controversy of Renin-Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection.
Manolis AS; Manolis TA; Manolis AA; Melita H
J Cardiovasc Pharmacol; 2020 Oct; 76(4):397-406. PubMed ID: 32769760
[TBL] [Abstract][Full Text] [Related]
37. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-converting enzyme 2 in acute respiratory distress syndrome.
Imai Y; Kuba K; Penninger JM
Cell Mol Life Sci; 2007 Aug; 64(15):2006-12. PubMed ID: 17558469
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.
Karakaş Çelik S; Çakmak Genç G; Pişkin N; Açikgöz B; Altinsoy B; Kurucu İşsiz B; Dursun A
J Med Virol; 2021 Oct; 93(10):5947-5952. PubMed ID: 34170561
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.
Cure E; Cumhur Cure M
Diabetes Metab Syndr; 2020; 14(4):349-350. PubMed ID: 32311651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
